Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 15/20 | 0.72 |
| ▸ | ITGA4 | P13612 | 9/20 | 0.72 |
| ▸ | ITGB7 | P26010 | 5/20 | 0.64 |
| ▸ | ITGA5 | P08648 | 4/20 | 0.61 |
| ▸ | ITGAV | P06756 | 5/20 | 0.54 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.51 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | ITGA2 | P17301 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6368888 | 0.93 | ITGB1 (0.73) | ITGB1ITGA4ITGB7ITGA5ITGAV | |
| SCHEMBL6368398 | 0.92 | ITGA4 (0.69) | ITGB1ITGA4ITGB7ITGA5ITGAV | |
| SCHEMBL6368195 | 0.92 | ITGB1 (0.64) | ITGB1ITGA4ITGB7ITGA5ITGAV | |
| SCHEMBL5687080 | 0.89 | ITGA4 (0.66) | ITGB1ITGA4ITGB7ITGA5ITGAV | |
| SCHEMBL6372387 | 0.89 | ITGA4 (0.66) | ITGB1ITGA4ITGB7ITGA5ITGAV | |
| SCHEMBL6367132 | 0.88 | ITGA4 (0.66) | ITGB1ITGA4ITGB7ITGA5ITGAV | |
| SCHEMBL6367902 | 0.88 | ITGB1 (0.59) | ITGB1ITGA4ITGB7ITGA5ITGAV | |
| SCHEMBL6374288 | 0.88 | ITGB1 (0.68) | ITGB1ITGA4ITGB7ITGA5ITGAV | |
| SCHEMBL6367317 | 0.87 | ITGB1 (0.65) | ITGB1ITGA4ITGB7ITGA5ITGAV | |
| SCHEMBL6367900 | 0.87 | ITGA4 (0.63) | ITGB1ITGA4ITGB7ITGA5ITGAV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1001764-A4 | HETEROCYCLIC AMIDE COMPOUNDS AS CELL ADHESION INHIBITORS | MERCK & CO INC (US) | 2005-08-24 | — | — | EP | claimed |
| US-6903075-B1 | Heterocyclic amide compounds as cell adhesion inhibitors | MERCK & CO., INC. (US) | 2005-06-07 | — | — | US | claimed |
| JP-2002512625-A | — | — | 2002-04-23 | — | — | JP | claimed |
| EP-1001764-A1 | HETEROCYCLIC AMIDE COMPOUNDS AS CELL ADHESION INHIBITORS | Merck & Co., Inc. (a New Jersey corp.) (US) | 2000-05-24 | — | — | EP | claimed |
| WO-1999064395-A1 | HETEROCYCLIC AMIDE COMPOUNDS AS CELL ADHESION INHIBITORS | MERCK & CO., INC. (US) | 1999-12-16 | — | — | WO | claimed |
| WO-1998053814-A1 | HETEROCYCLIC AMIDE COMPOUNDS AS CELL ADHESION INHIBITORS | MERCK & CO., INC. (US) | 1998-12-03 | — | — | WO | claimed |